Brief: Synact Pharma Informs About Termination Of Coverage Agreement With Redeye
Sept 1 (Reuters) - SynAct Pharma AB SYNACT.TE :
* SYNACT PHARMA INFORMS ABOUT TERMINATION OF COVERAGE
AGREEMENT
WITH REDEYE
Source text for Eikon: ID:nWkr4TP5d4
Further company coverage: SYNACT.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on SynAct Pharma AB
See all newsSweden's SynAct Pharma Q3 net loss narrows as expenses fall
Brief: SynAct Pharma Q3 Net Income SEK -32.177 Million
Brief: SynAct Pharma Signs First Commercial Partnership For Resomelagon
Brief: WHO Names Resomelagon Among Key Dengue Drug Candidates
Brief: SynAct Pharma Says Advance Analysis Supports Phase 3 Development